Premium
Transgenic mouse lines expressing the 3x FLAG ‐ dC as9 protein for enCh IP analysis
Author(s) -
Fujita Toshitsugu,
Kitaura Fusako,
Oji Asami,
Tanigawa Naoki,
Yuno Miyuki,
Ikawa Masahito,
Taniuchi Ichiro,
Fujii Hodaka
Publication year - 2018
Publication title -
genes to cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 115
eISSN - 1365-2443
pISSN - 1356-9597
DOI - 10.1111/gtc.12573
Subject(s) - crispr , transgene , genetically modified mouse , biology , microbiology and biotechnology , gene , biochemistry
We developed the engineered DNA ‐binding molecule‐mediated chromatin immunoprecipitation (enCh IP ) technology to isolate specific genomic regions while retaining their molecular interactions. In enCh IP , the locus of interest is tagged with an engineered DNA ‐binding molecule, such as a modified form of the clustered regularly interspaced short palindromic repeats ( CRISPR ) system containing a guide RNA ( gRNA ) and a catalytically inactive form of Cas9 ( dC as9). The locus is then affinity‐purified to enable identification of associated molecules. In this study, we generated transgenic mice expressing 3x FLAG ‐tagged Streptococcus pyogenes dC as9 (3x FLAG ‐ dC as9) and retrovirally transduced gRNA into primary CD 4 + T cells from these mice for enCh IP . Using this approach, we achieved high yields of enCh IP at the targeted genomic region. Our novel transgenic mouse lines provide a valuable tool for enCh IP analysis in primary mouse cells.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom